BRIEF-Agenus Reports 72% Of Patients With Locally Advanced Dmmr Colon Cancer Had No Cancer Remaining At Surgery Following Six Weeks Of Bot+Bal In Phase 2 Neoasis Study At Esmo 2026
Reuters2026/10/25 11:01Agenus Inc AGEN.O:
AGENUS REPORTS 72% OF PATIENTS WITH LOCALLY ADVANCED DMMR COLON CANCER HAD NO CANCER REMAINING AT SURGERY FOLLOWING SIX WEEKS OF BOT+BAL IN PHASE 2 NEOASIS STUDY AT ESMO 2026
Source text: ID:nBw73zhM8a
Further company coverage: AGEN.O
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Brent Crude Fell 12.5% But Former Biden Advisor Warns Iran War Could Return
Cathie Wood Blames Anthropic’s CEO for AI Panic: Why Attack a Company Her Fund Backs?
Anthropic's $1.5 Trillion IPO: What Investors Should Know Before Buying
Why is the US Dollar Falling? Midterms, Yields, and a Critical Economic Test
Crypto prices
More
